Top Markets
#1 GEKKO GEKKO +53.94%
#2 Helium Helium +53.04%
#3 ADO Protocol ADO Protocol +38.94%
#4 Pons Pons +37.78%
#5 StonkBroker StonkBroker +35.42%
#6 TENDIES TENDIES +31.92%
#7 Prom Prom +29.47%
#8 Collector Crypt Collector Crypt +29.31%
#9 o1.exchange o1.exchange +20.60%
#10 Cysic Cysic +20.33%
Coin of the day
GEKKO GEKKO
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Orum Therapeutics, Inc. Orum Therapeutics, Inc.

Orum Therapeutics, Inc.

475830
Rangering i aksjer #9664
Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the... Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutic solutions for both cancer and immune system conditions. The firm specializes in creating degrader-antibody conjugates, an innovative class of drugs that merges traditional antibody-drug conjugate (ADC) technology with targeted protein degradation. Their flagship product candidate, ORM-1153, functions as a GSPT1 protein degrader, specifically engineered to address hematologic malignancies. Orum Therapeutics was established in 2016 and operates out of Daejeon, South Korea.
Aksjekurs
$45.64
Sist synkronisert: 2026-08-28
Markedsverdi
$969.02M
Endring (1 dag)
-1.20%
Endring (1 år)
146.66%
Land
KR
Handel Orum Therapeutics, Inc. (475830)

Kategori

Healthcare
Inntekter for Orum Therapeutics, Inc. (475830)
Inntekter i 2026 TTM: 0
Ifølge Orum Therapeutics, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Orum Therapeutics, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH